- Home
- CVM vs GNTA Comparison
CVM vs GNTA Comparison
Compare CVM & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVM
- GNTA
- Stock Information
- Founded
- CVM 1983
- GNTA 2014
- Country
- CVM United States
- GNTA Italy
- Employees
- CVM N/A
- GNTA N/A
- Industry
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CVM Health Care
- GNTA Health Care
- Exchange
- CVM Nasdaq
- GNTA Nasdaq
- Market Cap
- CVM 53.1M
- GNTA 59.7M
- IPO Year
- CVM 1987
- GNTA 2021
- Fundamental
- Price
- CVM $6.71
- GNTA $2.17
- Analyst Decision
- CVM
- GNTA
- Analyst Count
- CVM 0
- GNTA 0
- Target Price
- CVM N/A
- GNTA N/A
- AVG Volume (30 Days)
- CVM 91.8K
- GNTA 2.0M
- Earning Date
- CVM 08-14-2025
- GNTA 01-01-0001
- Dividend Yield
- CVM N/A
- GNTA N/A
- EPS Growth
- CVM N/A
- GNTA N/A
- EPS
- CVM N/A
- GNTA N/A
- Revenue
- CVM N/A
- GNTA N/A
- Revenue This Year
- CVM N/A
- GNTA N/A
- Revenue Next Year
- CVM N/A
- GNTA N/A
- P/E Ratio
- CVM N/A
- GNTA N/A
- Revenue Growth
- CVM N/A
- GNTA N/A
- 52 Week Low
- CVM $1.98
- GNTA $2.10
- 52 Week High
- CVM $32.70
- GNTA $10.00
- Technical
- Relative Strength Index (RSI)
- CVM 35.37
- GNTA 41.80
- Support Level
- CVM $6.50
- GNTA $2.15
- Resistance Level
- CVM $7.36
- GNTA $2.32
- Average True Range (ATR)
- CVM 0.63
- GNTA 0.32
- MACD
- CVM -0.06
- GNTA -0.06
- Stochastic Oscillator
- CVM 18.32
- GNTA 4.65
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.